Ethambutol Hydrochloride/Isoniazid/Pyrazinamide/Rifampicin

Product Name :
Ethambutol Hydrochloride/Isoniazid/Pyrazinamide/Rifampicin

Search keywords :
Pyrazinamide

drugId :
null

Target Vo:
Fatty acid synthase

Target Vo Short Name :
FAS

Moa_Name:
Fatty acid synthase inhibitors

First Approval Country :
Denmark

First Approval Date Filter:
2003

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Novartis Pharma Ag

Active Indication_Name:
Tuberculosis, Pulmonary

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MLH1 Antibody (YA703)
Insulin Antibody
BNIP3L Antibody: BNIP3L Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 24 kDa, targeting to BNIP3L. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts